Joel Greenblatt’s Vaxart VXRT Stock Holding History

Joel Greenblatt’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-13,896	Closed	-$79K	–	1100
2020 Q4	$79K	Buy	+13,896	New	+$88.4K	﹤0.01%	970
2020 Q3	–	Sell	-11,048	Closed	-$98K	–	1144
2020 Q2	$98K	Buy	+11,048	New	+$31.7K	﹤0.01%	1014

Other funds holding VXRT

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Joel Greenblatt's VXRT Position: Q1 2021 in Review

Joel Greenblatt sold out of Vaxart (VXRT) in Q1 2021, closing a stake of 13,896 shares — an estimated $79K sold.

Joel Greenblatt first reported a position in VXRT in Q2 2020 and held it in 2 quarters. The position peaked at $98K in Q2 2020. 159 funds tracked by Wall St. Rank hold VXRT as of Q1 2021.

Joel Greenblatt reported no remaining Vaxart position as of Q1 2021 after selling out during the quarter.
Joel Greenblatt sold 13,896 Vaxart shares in Q1 2021, an estimated $79K.
Joel Greenblatt first reported a position in Vaxart in Q2 2020 and held it in 2 quarters.
Joel Greenblatt's Vaxart position peaked at $98K in Q2 2020.
159 funds tracked by Wall St. Rank held Vaxart as of Q1 2021.

Based on Gotham Asset Management's 13F filing for Q1 2021, filed 17 May 2021.